Compare REAL & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REAL | NAUT |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 256.4M |
| IPO Year | 2019 | N/A |
| Metric | REAL | NAUT |
|---|---|---|
| Price | $16.24 | $2.00 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 246.1K |
| Earning Date | 11-10-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $662,789,000.00 | N/A |
| Revenue This Year | $17.10 | N/A |
| Revenue Next Year | $10.90 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.30 | N/A |
| 52 Week Low | $4.61 | $0.62 |
| 52 Week High | $16.33 | $2.54 |
| Indicator | REAL | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 68.97 | 54.55 |
| Support Level | $15.13 | $1.91 |
| Resistance Level | $16.08 | $2.03 |
| Average True Range (ATR) | 0.78 | 0.15 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 96.11 | 61.11 |
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.